Day 13 of 30 Days of PH Topic: Growing Up With PH This is Tatiana’s story…
Articles by Bionews Staff
FFF Enterprises and Bionews announced today that both rare and orphan disease advocates are joining forces to provide patients with…
According to a study published by researchers at Novartis Pharma, common medications for severe pulmonary arterial hypertension interact, increasing…
Funding and awards from disease advocacy groups are usually given to scientists or clinicians and earmarked for research on…
A recent article on the University of New Mexico’s athletics news page profiles the return of a former UNM…
Back in early June, Pulmonary Hypertension News profiled PH advocates Team Phenomenal Hope and their compelling bicycle trek through twelve…
Earlier in the month, Pulmonary Hypertension News Contributing Editor Charles Moore reported on how, according to Canada’s Pulmonary Hypertension…
Drug maker Actelion has indicated that the company’s Food and Drug Administration (FDA)–approved pulmonary arterial hypertension (PAH) drug Bosentan, which is also known under…
Rensselaer, New York-based biopharmaceutical company Pulmokine recently made a major announcement regarding the company’s efforts in developing a novel therapy…
Among the fives types of PH, Pulmonary Arterial Hypertension (PAH) is recognized as a serious unmet medical need in terms…